Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Analyzing COVID-19 Impact on Hemodialysis Equipment Market | Asahi Kasei Corp., Baxter International Inc., and B. Braun Melsungen AG to Emerge as Major Vendors | Technavio


NEW YORK, May 7, 2021 /PRNewswire/ -- 

The hemodialysis equipment market is expected to grow by USD 3.57 billion during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of COVID-19 pandemic on the hemodialysis equipment market in optimistic, probable, and pessimistic forecast scenarios.

Enterprises will go through the Response, Recovery, and Renew phases.
Download the Free Sample Report on COVID-19 

The hemodialysis equipment market will witness a positive impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio's pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020.

With the continuing spread of the novel coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.

This post-pandemic business planning research will aid clients to:

Download the Post-Pandemic Business Planning Structure

Key Considerations for Market Forecast:

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform

Related Report on Healthcare Include:
Global Dialysis Catheters Market - Global dialysis catheters market is segmented by product (chronic dialysis catheters and acute dialysis catheters), end-user (in-center dialysis and home dialysis), and geography (Asia, Europe, North America, and ROW).
Download Exclusive Free Sample Report

Global Renal Dialysis Market - Global renal dialysis market is segmented by end-user (In-center dialysis and Home dialysis), geography (North America, APAC, Europe, and ROW), and type (hemodialysis, peritoneal dialysis, and others).
Download Exclusive Free Sample Report

Major Three Hemodialysis Equipment Market Participants:
Asahi Kasei Corp.
The company offers its product MDS 101 dialysis equipment system for ultrafiltration and simplified procedures.

Baxter International Inc.
The company provides their AK 98 machine and expanded hemodialysis (HDx) therapy enabled by Theranova membrane.

B. Braun Melsungen AG
The company provides Dialog+, bioLogic RR Comfort and ABPM machines for hemodialysis assistance.

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Get report snapshot for a detailed market share analysis of market participants during COVID-19 lockdown:
https://www.technavio.com/report/hemodialysis-equipment-market-industry-analysis

Hemodialysis Equipment Market 2021-2025: Segmentation
Hemodialysis equipment market is segmented as below:

The hemodialysis equipment market is driven by the increasing prevalence of chronic diseases and related risk factors. In addition, technological advances and new product launches are expected to trigger the hemodialysis equipment market toward witnessing a CAGR of over 4% during the forecast period.

Get more insights about the global trends impacting the future of the hemodialysis equipment market, Request Free Sample @ https://www.technavio.com/talk-to-us?report=IRTNTR40103

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Report: www.technavio.com/report/hemodialysis-equipment-market-industry-analysis

SOURCE Technavio


These press releases may also interest you

at 08:40
PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") , a biotechnology company focused on the research, development, and manufacturing of LaNeotm MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to announce that, further...

at 08:33
Prescient Healthcare Group, a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors ? Dr. Luke Solon and Debbie Allman ? to help shape and drive Prescient's global mission....

at 08:31
Snufff, the innovative nasal inhaler, emerges onto the wellness and lifestyle scene, offering a refreshing blend of enjoyment and health benefits. Crafted in the vibrant heart of Singapore, Snufff aims to revolutionize the way we approach personal...

at 08:31
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") , a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the...

at 08:15
MGI Tech, a company committed to building core tools and technology to lead life science, is proud to announce that its DNBSEQ-T20x2* gene sequencer has been recognized with a Gold Edison Award in the "Health, Medical & Biotech" category....

at 08:05
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Company sought an extension of its previously announced stay of proceedings ("Stay") under the Companies' Creditors Arrangement Act (the "CCAA") at a hearing before the Ontario...



News published on and distributed by: